Stockreport

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF WINSTON-SALEM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapy compan [Read more]